000 | 01268 a2200349 4500 | ||
---|---|---|---|
005 | 20250512032646.0 | ||
264 | 0 | _c19881115 | |
008 | 198811s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRochette-Egly, C | |
245 | 0 | 0 |
_aModulation of HT-29 human colonic cancer cell differentiation with calmidazolium and 12-O-tetradecanoylphorbol-13-acetate. _h[electronic resource] |
260 |
_bCancer research _cNov 1988 |
||
300 |
_a6173-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntigens, Neoplasm _xanalysis |
650 | 0 | 4 |
_aCalmodulin _xanalysis |
650 | 0 | 4 |
_aCalmodulin-Binding Proteins _xanalysis |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aColonic Neoplasms _xpathology |
650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aSucrase-Isomaltase Complex _xanalysis |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
700 | 1 | _aKedinger, M | |
700 | 1 | _aHaffen, K | |
773 | 0 |
_tCancer research _gvol. 48 _gno. 21 _gp. 6173-82 |
|
999 |
_c3054467 _d3054467 |